X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Deep Track Capital, LP reported a 8.33% stake in X4 Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Deep Track Capital, LP reported a 8.33% stake in X4 Pharmaceuticals, Inc., 8,040,894 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 8.33%
- Shares
- 8,040,894
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 8.33% | 8,040,894 |
| Deep Track Biotechnology Master Fund, Ltd. | 7.18% | 6,923,680 |
| David Kroin | 8.33% | 8,040,894 |
| Deep Track Special Opportunities Fund, LP. | 1.16% | 1,117,214 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Deep Track Capital, LP
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G · Deep Track Capital, LP · Aug 19, 2025
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026